Company news

Beyond Air, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Beyond Air Receives CE Mark in Europe for the LungFit® PH System

December 1, 2024

Beyond Air® Reports Fiscal Second Quarter 2025 Financial Results and Provides Corporate Update

November 10, 2024

Beyond Air® Schedules Second Fiscal Quarter 2025 Financial Results Conference Call and Webcast

October 28, 2024

Beyond Air Partners with Healthcare Links to Expand Access to LungFit® PH System Through Group Purchasing Organizations and Integrated Delivery Networks

October 1, 2024

Beyond Air Provides LungFit® PH System to U.S. Naval Hospital Guam for Neonatal Critical Care in Partnership with TrillaMed

September 26, 2024

Beyond Air Announces Termination of the Loan and Security Agreements with Avenue Capital

September 26, 2024

Beyond Air Announces $20.6 Million Private Placement Offering Priced At-the-Market Under Nasdaq Rules

September 26, 2024

Beyond Air® Reports Fiscal First Quarter 2025 Financial Results and Provides Corporate Update

August 5, 2024

Beyond Air® Reports Fiscal Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

June 23, 2024

Beyond Air® Appoints David Webster as Chief Commercial Officer

June 12, 2024

Beyond Air® Schedules Fiscal Year End 2024 Financial Results Conference Call and Webcast

May 22, 2024

Beyond Air® Announces Pricing of $16.0 Million Registered Direct Offering of Common Stock and Warrants

March 19, 2024

Beyond Air® Reports Financial Results for Third Quarter of Fiscal Year 2024

February 11, 2024

Beyond Air® Schedules Third Fiscal Quarter 2024 Financial Results Conference Call and Webcast

January 17, 2024

Beyond Cancer™ Phase 1 Study Clears Cohort 1 in Patients with Advanced Relapsed or Refractory Unresectable Primary or Metastatic Cutaneous or Subcutaneous Solid Tumors

December 26, 2023

Beyond Air® Reports Financial Results for Second Quarter of Fiscal Year 2024

November 12, 2023

Beyond Cancer™ Presents Positive First-in-Human Clinical Data for Ultra-High Concentration Nitric Oxide (UNO) Therapy in Solid Tumors During the Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting

November 2, 2023

Beyond Air® Schedules Second Fiscal Quarter 2024 Financial Results Conference Call and Webcast

October 18, 2023

Beyond Cancer™ Presents Positive Preclinical Data for Ultra-High Concentration Nitric Oxide (UNO) in Combination with Checkpoint Inhibitor Therapy During the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

October 15, 2023

Beyond Air® Receives Innovative Technology Contract from Vizient for LungFit®PH

October 15, 2023

Beyond Cancer™ to Present Initial Clinical Data for Ultra-High Concentration Nitric Oxide Therapy at the 2023 SITC Annual Meeting

September 26, 2023

Beyond Air® Announces Publication of Positive New Preclinical Data for the Treatment of Autism Spectrum Disorder

September 17, 2023

Beyond Air® and Getz Healthcare Enter Strategic Collaboration to Commercialize LungFit PH in Asia-Pacific Region

September 6, 2023

Beyond Air® Reports Financial Results for First Quarter of Fiscal Year 2024

August 9, 2023

Beyond Air® Announces Positive Preclinical Data on Role of Nitric Oxide in Autism Spectrum Disorder (ASD)

August 6, 2023

Beyond Air® Schedules First Fiscal Quarter 2024 Financial Results Conference Call and Webcast

July 23, 2023

Beyond Air® Reports Financial Results for Fourth Quarter and Fiscal Year-End 2023

June 21, 2023

Beyond Air® Secures up to $40 Million Debt Financing

June 14, 2023

Beyond Air® Licenses Commercial Rights to Selective Neuronal Nitric Oxide Synthase (nNOS) Inhibitors for the Treatment of Autism Spectrum Disorder from Hebrew University of Jerusalem

June 14, 2023

Beyond Air® Schedules Fiscal Year End 2023 Financial Results Conference Call and Webcast

May 15, 2023

Beyond Cancer™ Presents Positive Preclinical Data for Ultra-High Concentration Nitric Oxide (UNO) Therapy in Solid Tumors During the American Association for Cancer Research (AACR) 2023 Annual Meeting

April 18, 2023

Beyond Air® Appoints Jeff Myers, M.D. Ph.D. as Chief Medical Officer

March 22, 2023

Beyond Cancer™ to Present Two Posters for Ultra-High Concentration Nitric Oxide (UNO) Therapy at the 2023 AACR Annual Meeting

March 13, 2023

Beyond Air® Announces Participation at Two Upcoming Investor Conferences in March 2023

February 21, 2023

Beyond Air® Reports Financial Results for the Third Quarter of Fiscal Year 2023

February 8, 2023

Beyond Cancer® Appoints Gavin Choy, PharmD as Chief Operating Officer

January 29, 2023

Beyond Cancer® Announces Sponsored Research Agreement with Stanford and Appointment of Frederick M. Dirbas, MD and Mark D. Pegram, MD to Scientific Advisory Board

January 23, 2023

Beyond Air® Schedules Third Fiscal Quarter 2023 Financial Results Conference Call and Webcast

January 16, 2023

Beyond Cancer® Publishes Pre-Clinical Data in Cancer Cell International Demonstrating Its Tumor Ablation Method Utilizing Ultra-High Concentration Nitric Oxide (UNO) Induced a Systemic Response that Prevents Metastases

December 12, 2022

Beyond Cancer™ Presents Promising New In Vivo Data Showing Ultra-High Concentration Nitric Oxide Therapy (UNO) in Combination with Anti-PD-1 During the Society for Immunotherapy of Cancer (SITC) 2022 Annual Meeting

November 9, 2022

Beyond Air® Reports Financial Results for the Second Quarter of Fiscal Year 2023

November 7, 2022

Beyond Air® Announces Positive Data for Inhaled Nitric Oxide (NO) to Treat COVID-19 with LungFit® PRO in a Poster Presentation at IDWeek 2022

October 23, 2022

Beyond Air® Schedules Second Fiscal Quarter 2023 Financial Results Conference Call and Webcast

October 19, 2022

Beyond Air® Announces Positive Data from At-Home Pilot Study in Patients with Refractory NTM Lung Infection Treated with (NO) using the LungFit® GO at the CHEST Annual Meeting 2022

October 16, 2022

Beyond Cancer™ to Present Pre-Clinical Data for Ultra-High Concentration Nitric Oxide Therapy at the 2022 SITC Annual Meeting

October 4, 2022

Beyond Air® Announces that Annals of the American Thoracic Society Published a Review of the Third Pilot Study of High Dose Nitric Oxide for Bronchiolitis

October 2, 2022

Beyond Air® Affiliate Beyond Cancer™ Doses Initial Patient in First-in-Human Phase 1 Study of Ultra-High Concentration Nitric Oxide Therapy at Tel Aviv Sourasky Medical Center (Ichilov)

August 22, 2022

Beyond Air® Reports Financial Results for the First Quarter of Fiscal Year 2023

August 10, 2022

Beyond Air® Schedules First Fiscal Quarter 2023 Financial Results Conference Call and Webcast

July 26, 2022

Beyond Air’s LungFit® PH Receives FDA Approval to Treat Term and Near-Term Neonates with Hypoxic Respiratory Failure

June 27, 2022

← Newer news releases · Older news releases →

Calls

The 5 newest of 23 calls. Every call is listed under its year.

Decks

The 5 newest of 14 decks. Every deck is listed under its year.